Skip to main content
GutCited

Zinc Carnosine Peptic Ulcer Disease

B

Reduces NSAID-induced small bowel injury by 70% (measured by calprotectin). Promotes gastric mucosal healing. 75-150 mg/day as zinc carnosine complex.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dzinc\u002Dcarnosine\u0026condition\u003Dgastric\u002Dulcer'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Reduces NSAID-induced small bowel injury by 70% (measured by calprotectin). Promotes gastric mucosal healing. 75-150 mg/day as zinc carnosine complex.

Key Study Findings

Randomized Controlled Trial n=92
Zinc carnosine-based modified bismuth quadruple therapy vs standard triple therapy for Helicobacter pylori eradication: A …
Dose: Zinc carnosine 75 mg twice daily for 10 days vs: Standard triple therapy for 14 days Outcome: H. pylori eradication rate 効果: 93.5% vs 69.6% P=0.003

対象集団: Dyspepsia patients with H. pylori infection

In Vitro
The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats.
Dose: 30 mg/kg vs: None Outcome: mineral status 効果: or 2 None

対象集団: animal model

Key Statistics

6

研究数

500

参加者数

Positive

B

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
75 mg twice daily (as zinc carnosine complex)
nsaidprotection:
37.5-75 mg twice daily alongside NSAID therapy
gastricprotection:
75 mg twice daily for 8 weeks

上限量: 40 mg/day elemental zinc (equivalent to ~340 mg zinc carnosine); risk of copper depletion above this

研究で検討された用量

用量 期間 効果 N
Zinc carnosine 75 mg twice daily for 10 days -- Positive 92
30 mg/kg -- Positive --

推奨摂取タイミング: On an empty stomach or between meals for gastric mucosal contact; twice daily

Safety & Side Effects

報告されている副作用

  • Nausea (most common, usually transient)
  • Metallic taste
  • Copper depletion with long-term high-dose use (>40 mg elemental zinc/day)
  • Headache

既知の相互作用

  • Tetracycline and quinolone antibiotics (zinc reduces absorption; space 2 hours)
  • Penicillamine (zinc reduces absorption)
  • Copper supplements (zinc competes with copper for absorption)
  • Bisphosphonates (zinc may reduce absorption; space 2 hours)

耐容上限摂取量: 40 mg/day elemental zinc (equivalent to ~340 mg zinc carnosine); risk of copper depletion above this

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Zinc Carnosine help with Peptic Ulcer Disease?
Based on 6 studies with 500 participants, there is moderate evidence from clinical studies that Zinc Carnosine may support Peptic Ulcer Disease management. Our evidence grade is B (Good Evidence).
How much Zinc Carnosine should I take for Peptic Ulcer Disease?
Studies have used various dosages. A commonly studied range is 75 mg twice daily (as zinc carnosine complex). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Zinc Carnosine?
Reported side effects may include Nausea (most common, usually transient), Metallic taste, Copper depletion with long-term high-dose use (>40 mg elemental zinc/day), Headache. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Zinc Carnosine and Peptic Ulcer Disease?
We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 500 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Peptic Ulcer Disease

Zinc Carnosine 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。